İçeriğe geç
akaturk Akademik ölçüm
Akademik özet YÖKSİS ve OpenAlex ayrı sayılır.
Makale 97
YÖKSİS97 OpenAlex0
Proje 1
Kitap 6
Bildiri 275

Atıf etkisi

OpenAlex YÖKSİS makalelerinden OpenAlex’te eşleşen: 34
h-indeks 12 Türkiye yüzdelik dilimi: 90 Üniversitesinde h-indekse göre 186. / 1.074
i10-indeks
15
Toplam atıf
487
Türkiye’de üst %11
Makale başına
14,3
FWCI
1,08
1,00 = dünya ortalaması
Dünyada üst %1
0
Dünyada üst %10
3

h-indeks ve atıflar, bu akademisyenin YÖKSİS makalelerinden OpenAlex’te eşleşenlerin atıf sayılarından hesaplanır (Google Scholar, WoS veya Scopus değildir). Eşleşmeyen makalelerin atıfı dahil değildir.

Alan sıralaması

YÖKSİS ?

Dizin çeyrekleri

?
Scopus (SJR) 78
  • Q1 19
  • Q2 35
  • Q3 17
  • Q4 8
WoS (JCR) 73
  • Q1 10
  • Q2 25
  • Q3 23
  • Q4 16
TR Index TR Index

25 makale

OpenAlex atıf yüzdelik
  • Üst %1 0
  • Üst %10 4
  • Ort. 70.0%
  • n 44
Diğer sayımlar

Scopus (SJR)

  • Özet hariç 75 Q1 17 Q2 34 Q3 17 Q4 8
  • En iyi Q 78 Q1 19 Q2 34 Q3 17 Q4 8
  • YÖKSİS satırı 125

WoS (JCR)

  • Özet hariç 70 Q1 8 Q2 24 Q3 23 Q4 16
  • En iyi Q 73 Q1 10 Q2 25 Q3 22 Q4 16
  • YÖKSİS satırı 120

TR Index

  • YÖKSİS satırı 37 makale

Makaleler

YÖKSİS ve OpenAlex kaynak ayrımıyla makaleler; quartile ve TR Index ile daraltabilirsiniz.

Yayını olan dergiler

39 dergi

Makale listesi

  1. 2025 A biopsychosocial questionnaire for patients with primary Sjögren’s syndrome: The BETY-Biopsychosocial Questionnaire Modern Rheumatology DOI 10.1093/mr/roae085 2 YÖKSİS kaydı YÖKSİS
  2. 2025 Comparison of functionality, mood, and biopsychosocial status in rheumatic patients with and without self-reported bowel problems and the evaluation of BETY’s impact on these factors: a retrospective study Current Medical Research and Opinion DOI 10.1080/03007995.2025.2486164 YÖKSİS SJR Q2 JCR Q1
  3. 2025 Correction: Biopsychosocial model-based exercise improves muscle strength, proprioception, pain, function, and quality of life in rheumatoid arthritis patients with knee involvement: a randomized controlled clinical trial Rheumatology International DOI 10.1007/s00296-025-05999-w YÖKSİS SJR Q2 JCR Q2
  4. 2025 Behçets disease beyond the criteria: insights from a tertiary centre in Turkey Clinical and Experimental Rheumatology DOI 10.55563/clinexprheumatol/h8mxc6 YÖKSİS SJR Q2 JCR Q2
  5. 2025 Biopsychosocial model-based exercise improves muscle strength, proprioception, pain, function, and quality of life in rheumatoid arthritis patients with knee involvement: a randomized controlled clinical trial (vol 45, 221, 2025) rheumatology international DOI 10.1007/s00296-025-05999-w YÖKSİS SJR Q2 JCR Q2
  6. 2025 Differences and Similarities Between Children and Adults With Rhupus Syndrome International Journal of Rheumatic Diseases DOI 10.1111/1756-185X.70082 YÖKSİS SJR Q3 JCR Q3
  7. 2025 Biyolojik DMARD kullanan veya başlanacak olan seropozitif ve seronegatif romatoid artrit hastalarının karşılaştırılması Ulusal Romatoloji Dergisi DOI 10.4274/raed.galenos.2025.22043 YÖKSİS TR Index SJR Q4
  8. 2024 The validity, reliability, and responsiveness of a new biopscyhosocial questionnaire for patients with systemic lupus erythematosus Current Medical Research and Opinion DOI 10.1080/03007995.2024.2362281 YÖKSİS SJR Q2 JCR Q2
  9. 2024 Transitioning from pediatric to adult-oriented healthcare in rheumatology: the pediatric side of the coin Rheumatology DOI 10.1093/rheumatology/keae254 YÖKSİS SJR Q1 JCR Q1
  10. 2024 Assessment and comparison of the 2023 ACR/EULAR APS criteria with the revised Sapporo criteria International Journal of Rheumatic Diseases DOI 10.1111/1756-185X.15175 YÖKSİS SJR Q3 JCR Q3
  11. 2023 Fertility, early menopause and pregnancy outcomes of patients with Takayasu’s arteritis Elsevier BV DOI 10.1016/j.ejogrb.2023.01.021 YÖKSİS SJR Q2 JCR Q2
  12. 2023 Hematologic Malignancy Risk in Inflammatory Arthritis Patients Treated with TNF Inhibitors: The Real-Life Data from the HUR-BIO Registry Rheumatology and Therapy DOI 10.1007/s40744-023-00563-z YÖKSİS SJR Q2 JCR Q2
  13. 2023 Factors that predict development of chronic kidney disease in patients with rheumatoid arthritis receiving biologic DMARDs and mortality rates Wiley DOI 10.1111/1756-185X.14967 YÖKSİS SJR Q3 JCR Q2
  14. 2023 Drug retention rate and predictive factors of drug survival for secukinumab in radiographic axial spondyloarthritis RHEUMATOLOGY INTERNATIONAL DOI 10.1007/s00296-022-05213-1 2 YÖKSİS kaydı YÖKSİS SJR Q2 JCR Q2
  15. 2023 Comparison of demographic, clinic and radiological features of patients with axial spondyloarthritis accompanying familial Mediterranean fever to patients with each condition alone SCANDINAVIAN JOURNAL OF RHEUMATOLOGY DOI 10.1080/03009742.2022.2143621 YÖKSİS SJR Q2 JCR Q3
  16. 2023 The impact of antiphospholipid antibodies in Takayasu arteritis Turkish Journal Of Medical Sciences DOI 10.55730/1300-0144.5573 YÖKSİS TR Index SJR Q3 JCR Q2
  17. 2023 Association between oxygen delivery and digital ulcers in systemic sclerosis Elsevier BV DOI 10.1016/j.mvr.2022.104449 2 YÖKSİS kaydı YÖKSİS SJR Q2 JCR Q2 OpenAlex 54.2%
  18. 2023 Do we underestimate musculoskeletal ultrasonography in the diagnosis of polymyalgia rheumatica with or without giant cell arteritis? Journal of Turkish Society for Rheumatology DOI 10.4274/raed.galenos.2023.21939 YÖKSİS TR Index SJR Q4
  19. 2022 Is the impact of biologic agents in enteropathic spondylitis different from other spondylitis? Real life data from the HUR-BIO Registry Clinical and Experimental Rheumatology DOI 10.55563/clinexprheumatol/uxcofr 2 YÖKSİS kaydı YÖKSİS SJR Q2 JCR Q3
  20. 2022 The clinical features and treatment of eosinophilic granulomatosis with polyangiitis (EGPA) in Turkey: one or two distinct diseases? Springer Science and Business Media LLC DOI 10.1007/s11739-021-02863-0 4 YÖKSİS kaydı YÖKSİS SJR Q1 JCR Q2

Akademisyenlere dön